4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-23-019556
Director acquired 280,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Press Joseph Director | 2022-07-26 | Grant or award | +280,000 | 280,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Press Joseph Director | 2022-12-05 | Grant or award · Warrants to Purchase Common Stock | +105,000 | 105,000 | D: show line 2 in the form |
Loading xslF345X03/ownership.xml…